agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $1.42 billion. The enterprise value is $1.22 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 16.68 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Current Share Class | 16.68M |
| Shares Outstanding | 16.68M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 2.12% |
| Owned by Institutions (%) | 54.37% |
| Float | 9.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| Forward PS | 0.25 |
| PB Ratio | 7.80 |
| P/TBV Ratio | 11.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.04 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.13 |
Financial Efficiency
Return on equity (ROE) is -109.59% and return on invested capital (ROIC) is -64.29%.
| Return on Equity (ROE) | -109.59% |
| Return on Assets (ROA) | -14.16% |
| Return on Invested Capital (ROIC) | -64.29% |
| Return on Capital Employed (ROCE) | -167.39% |
| Weighted Average Cost of Capital (WACC) | 16.92% |
| Revenue Per Employee | $6.80M |
| Profits Per Employee | -$414,186 |
| Employee Count | 856 |
| Asset Turnover | 3.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $1.08 million in taxes.
| Income Tax | 1.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.64% in the last 52 weeks. The beta is 2.30, so agilon health's price volatility has been higher than the market average.
| Beta (5Y) | 2.30 |
| 52-Week Price Change | +53.64% |
| 50-Day Moving Average | 34.28 |
| 200-Day Moving Average | 24.35 |
| Relative Strength Index (RSI) | 76.49 |
| Average Volume (20 Days) | 605,686 |
Short Selling Information
The latest short interest is 791,524, so 4.74% of the outstanding shares have been sold short.
| Short Interest | 791,524 |
| Short Previous Month | 1.36M |
| Short % of Shares Out | 4.74% |
| Short % of Float | 8.05% |
| Short Ratio (days to cover) | 1.85 |
Income Statement
In the last 12 months, agilon health had revenue of $5.82 billion and -$354.54 million in losses. Loss per share was -$21.38.
| Revenue | 5.82B |
| Gross Profit | -145.73M |
| Operating Income | -389.38M |
| Pretax Income | -372.46M |
| Net Income | -354.54M |
| EBITDA | -374.58M |
| EBIT | -389.38M |
| Loss Per Share | -$21.38 |
Full Income StatementBalance Sheet
The company has $231.41 million in cash and $33.40 million in debt, with a net cash position of $198.01 million or $11.87 per share.
| Cash & Cash Equivalents | 231.41M |
| Total Debt | 33.40M |
| Net Cash | 198.01M |
| Net Cash Per Share | $11.87 |
| Equity (Book Value) | 181.43M |
| Book Value Per Share | 10.93 |
| Working Capital | 48.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50.05 million and capital expenditures -$12.49 million, giving a free cash flow of -$62.54 million.
| Operating Cash Flow | -50.05M |
| Capital Expenditures | -12.49M |
| Depreciation & Amortization | 14.81M |
| Net Borrowing | -3.50M |
| Free Cash Flow | -62.54M |
| FCF Per Share | -$3.75 |
Full Cash Flow StatementMargins
Gross margin is -2.50%, with operating and profit margins of -6.69% and -6.09%.
| Gross Margin | -2.50% |
| Operating Margin | -6.69% |
| Pretax Margin | -6.40% |
| Profit Margin | -6.09% |
| EBITDA Margin | -6.44% |
| EBIT Margin | -6.69% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.61% |
| Shareholder Yield | -0.61% |
| Earnings Yield | -24.92% |
| FCF Yield | -4.40% |
Analyst Forecast
The average price target for agilon health is $60.36, which is -29.21% lower than the current price. The consensus rating is "Hold".
| Price Target | $60.36 |
| Price Target Difference | -29.21% |
| Analyst Consensus | Hold |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 3.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
agilon health has an Altman Z-Score of 1.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.55 |
| Piotroski F-Score | 2 |
